We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CYTK market cap is 6.71B. The company's latest EPS is USD -5.1089 and P/E is -12.77.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.52M | 1.96M | 4.61M | 867k | 378k |
| Operating Income | -108.44M | -127.03M | -124.47M | -122.05M | -122.27M |
| Net Income | -142.31M | -137.38M | -131.29M | -128.64M | -129.42M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 26.87M | 55.83M | 70.43M | 94.59M | 7.53M |
| Operating Income | -98.87M | -93.94M | -186.34M | -324.2M | -496.21M |
| Net Income | -121.69M | -127.29M | -215.34M | -388.96M | -526.24M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.08B | 1.01B | 889.82M | 779.9M | 740.61M |
| Total Liabilities | 1.09B | 1.12B | 1.12B | 1.11B | 1.18B |
| Total Equity | -15.98M | -107.9M | -229.02M | -333.12M | -438.8M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 289.81M | 533.8M | 841.32M | 1.01B | 824.32M |
| Total Liabilities | 300.75M | 420.42M | 597.46M | 1.12B | 1.21B |
| Total Equity | -10.94M | 113.38M | 243.86M | -107.9M | -386.32M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -201.33M | -299.52M | -122.29M | -244.09M | -340.3M |
| Investing | -291.38M | -262.13M | 165.5M | 247.63M | 320.66M |
| Financing | 486.28M | 516.17M | -7.18M | -1.7M | 52.52M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -90.91M | 8.94M | -142.52M | -299.52M | -414.33M |
| Investing | -74.71M | -196.52M | -147.78M | -262.13M | 239.25M |
| Financing | 159.79M | 234.12M | 319.98M | 516.17M | 221.32M |
| Market Cap | 6.71B |
| Price to Earnings Ratio | -12.77 |
| Price to Sales Ratio | 892.34 |
| Price to Cash Ratio | 59.45 |
| Price to Book Ratio | -17.39 |
| Dividend Yield | - |
| Shares Outstanding | 103M |
| Average Volume (1 week) | 1.19M |
| Average Volume (1 Month) | 1.06M |
| 52 Week Change | 71.80% |
| 52 Week High | 110.25 |
| 52 Week Low | 25.98 |
| Spread (Intraday) | 0.14 (0.21%) |
| Company Name | Cytokinetics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.cytokinetics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
